Co-op - Cell Production and Process Development
United Therapeutics Corporation
Summary
The selected Co-op will need to be onsite at the Manchester, NH office for the entire duration of this co-op role, from January 2027 - July 2027. The hours for the role are 9AM – 5:30PM.
Job description
This Co-op will assist a project lead/scientist within one or more of the following areas:
- Contribute to the execution of cell production runs to provide a reliable supply of primary and iPSC-derived cells for research and process development activities
- Assist with routine laboratory activities including equipment setup, reagent preparation, sample tracking, and data recording in alignment with PD best practices
- Assess cell differentiation and quality using cell imaging, cell counting, viability assays, and flow cytometry–based readouts
- Provide hands-on support for established QC and in-process testing to enable continued process development of in-house iPSC-derived cell products
- Assist with small-to-medium process development studies to develop, optimize, and scale robust, cGMP-compliant manufacturing processes for iPSC-derived cells including study planning, execution, data analysis, risk identification, and communication of results and recommendations
- Maintain laboratory records, technical reports, protocols, and other controlled documentation to support process development
- Assist in investigating process deviations, troubleshooting technical challenges, and identifying opportunities for process improvements that enhance manufacturing robustness, consistency, efficiency, and scalability
- Assist in evaluating emerging technologies, equipment, and manufacturing strategies to support continuous improvement initiatives, including participation in the selection, acquisition, implementation, and lifecycle management of laboratory and manufacturing equipment
- Communicate cross-functionally with members of the Cell Production and Process Development department and other company functions as needed
- Perform other duties as assigned
Requirements
- Must be currently enrolled in an accredited Bachelor Degree program in the field of Biology, Cell Biology, Biotechnology or similar
- Candidates must be receptive to learning, inquisitive, and self-motivated
- Knowledge of basic cell culture and cellular/molecular assays
- Knowledge of basic flow cytometry is desired
- Confident track record of antibiotic-free cell culture
- Experience working in a hands-on lab environment
- Strong attention to detail and experience following experimental methods and protocols
- Ability to retain sufficient records and keep electronic lab notebook records to the level of reproducibility
- Ability to communicate and collaborate cross-functionally, and utilize internal and external resources to resolve issues in creative, efficient, and effective ways
- Experience working with iPSCs, including maintenance and differentiation
- Experience with basic flow cytometry
- Knowledge of Bioreactor culture; hands-on experience is a plus
Benefits
- Medical Insurance
- Dental Insurance
- Vision Insurance
- Prescription Coverage
- Employee Wellness Resources
- 401(k)
- Employee Stock Purchase Plan
- Paid Time Off
- Paid Parental Leave
- Disability Benefits
Company overview
United Therapeutics Corporation is an American biotechnology company founded in 1996 with a deeply personal mission: to find a cure for pulmonary arterial hypertension (PAH) after the founder's daughter was diagnosed with this rare disease. Headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, the company has evolved into a pioneering force in biotechnology, focusing on developing novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. United Therapeutics specializes in treatments for pulmonary arterial hypertension, pulmonary hypertension associated with interstitial lung disease, neuroblastoma, and end-stage lung disease through its flagship products including Tyvaso, Remodulin, Orenitram, Adcirca, and Unituxin. The company is particularly notable for being the first publicly-traded biotech or pharmaceutical company to convert to a public benefit corporation (PBC), with a dual purpose of developing innovative pharmaceutical therapies and creating technologies that increase transplantable organ availability. Their groundbreaking work includes xenotransplantation research, organ manufacturing technologies, and regenerative medicine programs aimed at addressing critical shortages in transplantable organs. With approximately 1,001-5,000 employees and a strong commitment to corporate social responsibility, United Therapeutics has established itself as a leader in both patient-focused innovation and workplace excellence.